{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:43:50Z","timestamp":1760298230906,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.atherosclerosis.2010.03.002","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T07:15:27Z","timestamp":1268205327000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice"],"prefix":"10.1016","volume":"212","author":[{"given":"Magnus","family":"Baumh\u00e4kel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Custodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Schlimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2007.03.024","volume":"154","author":"Bohm","year":"2007","journal-title":"American Heart Journal"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/heart.89.3.251","article-title":"Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator","volume":"89","author":"Solomon","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1742-1241.2006.01274.x","article-title":"Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients","volume":"61","author":"Baumhakel","year":"2007","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1742-1241.2001.tb11141.x","article-title":"Is erectile dysfunction a marker for cardiovascular disease?","volume":"55","author":"Kirby","year":"2001","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0030","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.294.23.2996","article-title":"Erectile dysfunction and subsequent cardiovascular disease","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0035","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"American Heart Journal"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease","volume":"26","author":"Diaz","year":"2005","journal-title":"European Heart Journal"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0045","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9150(97)00202-5","article-title":"Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta 1-adrenoceptor activation","volume":"136","author":"Skantze","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0055","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1185\/030079905X50543","article-title":"Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents","volume":"21","author":"DiFrancesco","year":"2005","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0060","first-page":"H676","article-title":"Contributions of heart rate and contractility to myocardial oxygen balance during exercise","volume":"284","author":"Colin","year":"2003","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0065","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","article-title":"Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice","volume":"117","author":"Custodis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0070","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1743-6109.2007.00518.x","article-title":"A mouse model of hypercholesterolemia-induced erectile dysfunction","volume":"4","author":"Xie","year":"2007","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1743-6109.2006.00282.x","article-title":"Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice","volume":"3","author":"Behr-Roussel","year":"2006","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0080","article-title":"Nebivolol, but not Metoprolol improves endothelial function of the corpus cavernosum in ApoE-knockout-mice","author":"Baumhaekel","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01905-8","article-title":"Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice","volume":"472","author":"Buyukafsar","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.108.140533","article-title":"Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan","volume":"327","author":"Baumhakel","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/01.ATV.0000158311.24443.af","article-title":"Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis","volume":"25","author":"Laufs","year":"2005","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2004.07.004","article-title":"Endothelial function in patients with vasculogenic erectile dysfunction","volume":"103","author":"Yavuzgil","year":"2005","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/pmed.2000.0643","article-title":"Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study","volume":"30","author":"Feldman","year":"2000","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0110","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1172\/JCI119751","article-title":"Cellular and molecular mechanisms of endothelial cell dysfunction","volume":"100","author":"Harrison","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1126\/science.6484569","article-title":"Retarding effect of lowered heart rate on coronary atherosclerosis","volume":"226","author":"Beere","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00392-007-0537-5","article-title":"The role of heart rate in the development of cardiovascular disease","volume":"96","author":"Reil","year":"2007","journal-title":"Clinical Research in Cardiology"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjp.2008.116","article-title":"Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice","volume":"154","author":"Drouin","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0130","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(08)61172-1","article-title":"BEAUTIFUL results\u2013the slower, the better?","volume":"372","author":"Reil","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/ijir.2008.28","article-title":"Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome","volume":"20","author":"Baumhakel","year":"2008","journal-title":"International Journal of Impotence Research"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0741-5214(94)70069-9","article-title":"Hemodynamic stress and experimental aortoiliac atherosclerosis","volume":"19","author":"Bassiouny","year":"1994","journal-title":"Journal of Vascular Surgery"},{"key":"10.1016\/j.atherosclerosis.2010.03.002_bib0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1517\/14728222.10.3.445","article-title":"Nitric oxide\/redox-based signalling as a therapeutic target for penile disorders","volume":"10","author":"Burnett","year":"2006","journal-title":"Expert Opinion on Therapeutic Targets"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501000184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501000184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:34:08Z","timestamp":1758155648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501000184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S002191501000184X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.03.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}